(Q73784686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1 reference

U R Hengge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Esser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H P Rudel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Goos

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

878-883

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Liposomal doxorubicin in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Development of liposomal anthracyclines: from basics to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Ultrasound as a tool to evaluate remission of cutaneous Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Fatal hepatic failure with liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900053-3

7 January 2021

10.1016/S0959-8049(01)00053-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313176%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference